Cargando…
CORRIGENDUM: Correction of funding statement in ACKNOWLEDGEMENTS section: Epigenetic inactivation of RUNX3 in colorectal cancer
Autores principales: | Shin, Eung Jin, Kim, Han Jo, Son, Myoung Won, Ahn, Tae Sung, Lee, Hyun Yong, Lim, Dae Ro, Bae, Sang Byung, Jeon, Seob, Kim, Hyungjoo, Jeong, Dongjun, Lee, Moon Soo, Kim, Dong-Sun, Noh, Jeong Se, Baek, Moo-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Surgical Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842091/ https://www.ncbi.nlm.nih.gov/pubmed/29521382 http://dx.doi.org/10.4174/astr.2018.94.3.166 |
Ejemplares similares
-
Epigenetic inactivation of RUNX3 in colorectal cancer
por: Shin, Eung Jin, et al.
Publicado: (2018) -
Erratum: Funding Acknowledgment
por: Chung, Mi Ja, et al.
Publicado: (2012) -
Addition of funding statement: Clinical characteristics of papillary thyroid carcinoma arising from the pyramidal lobe
por: Yoon, Sang Gab, et al.
Publicado: (2017) -
Loss of RUNX3 is significantly associated with advanced tumor grade and stage in endometrial cancers
por: Jeong, Dongjun, et al.
Publicado: (2018) -
Erratum: Funding Acknowledgment
por: Baek, Jongmi, et al.
Publicado: (2013)